摘要
目的了解目前临床住院患者瓶装胰岛素的使用情况,为临床合理用药和瓶装胰岛素生产规格的优化提供依据。方法利用泸州市某三甲医院的医院信息系统（HIS）,调取2014年1~10月该医院住院患者使用瓶装胰岛素的种类、销售金额和各科室分布情况等进行统计和分析。结果从胰岛素的半衰期来看,该医院住院患者使用的瓶装胰岛素以短效为主,其中诺和灵R占62.61%;从销售金额来看,进口胰岛素是国产的5.8倍;从患者的需求来看,内分泌科、心血管内科等7个科室胰岛素使用量最大,占该医院使用总量的49.35%;从瓶装胰岛素的具体用量来看,除诺和灵R、N以外,其余5类胰岛素平均使用量少于1支/月的科室占使用该类胰岛素科室的比例高达75.76%~85.71%。结论瓶装胰岛素的使用存在浪费的情况,一方面科室应根据患者的需求量调整胰岛素的使用;另一方面应结合患者的使用量和各地区相关政策,积极探索瓶装胰岛素生产规格的优化,以减少药物浪费。
Objective To explore the utilization of bottled insulin for patients admitted,and provide a basis for rational use and optimization of bottled insulin production standard.Methods The types and sales sum of bottled insulin,as well as departments whose patients used the bottled insulin between January to October in 2014 were got from the hospital information system.Results Short-acting bottled insulin was mostly used,with Novolin R accounting for 62.61%.The sales sum of imported bottled insulin was 5.8times of that made in China.Patients from seven departments,such as department of endocrinology and cardiovascular medicine,used 49.35% of the total sum.The number of department whose average dosage of insulins except Novolin R and N less than one bottle per month was 75.76% to 85.71% of all departments using such insulin.Conclusion Much bottled insulin was wasted in clinical practice.Therefore,the usage of bottled insulin should be adjusted according to patients＇ need.The production standard should also be optimized according to clinical dosage and related local policies to avoid wasting drugs.
出处
《中国临床护理》
2016年第3期266-269,共4页
Chinese Clinical Nursing
关键词
住院患者
瓶装胰岛素
临床使用
Inpatients
Bottle of insulin
Clinical application
